Foldvari M, Radhi J, Yang G, He Z, Rennie R, Wearley L
College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada.
Mycoses. 2000;43(11-12):393-401.
A rat model of vaginal candidosis, suitable for screening new antifungal compounds or novel formulations was developed and validated. Two strains of Candida albicans, different inoculation schedules, quantitative assays for fungal burden and the necessity for immunosuppression were tested. The infection was evaluated clinically and histologically by fungal counts from the vaginal discharge. The animals without immunosuppression did not sustain the infection beyond 2-3 days, however, after immunosuppression with cyclophosphamide, the infection can be maintained for about 2 weeks and is suitable for the testing of topical antifungal therapies.
